BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24481607)

  • 1. Severe combined immunodeficiency in Serbia and Montenegro between years 1986 and 2010: a single-center experience.
    Pasic S; Vujic D; Veljković D; Slavkovic B; Mostarica-Stojkovic M; Minic P; Minic A; Ristic G; Giliani S; Villa A; Sobacchi C; Lilić D; Abinun M
    J Clin Immunol; 2014 Apr; 34(3):304-8. PubMed ID: 24481607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening.
    Al Sukaiti N; Ahmed K; Alshekaili J; Al Kindi M; Cook MC; Farsi TA
    Front Immunol; 2020; 11():623199. PubMed ID: 33519828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Immunological Features of 96 Moroccan Children with SCID Phenotype: Two Decades' Experience.
    Benhsaien I; Ailal F; El Bakkouri J; Jeddane L; Ouair H; Admou B; Bouskraoui M; Hbibi M; Hida M; Amenzoui N; Jouhadi Z; El Hafidi N; Rada N; Benajiba N; Abilkassem R; Badou A; Bousfiha AA
    J Clin Immunol; 2021 Apr; 41(3):631-638. PubMed ID: 33411152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe combined immunodeficiency, report of chilean patients diagnosed during the 1999-2020 period].
    Hoyos-Bachiloglu R; Rojas J; Borzutzky A; Hernández P; Vinet AM; Bustos P; Fernández F; Lagos M; Strickler A; Marinovic MA; Casado C; Poli MC; King A
    Rev Chil Pediatr; 2020 Dec; 91(6):908-916. PubMed ID: 33861827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and genetic profiles of 44 patients with severe combined immunodeficiency (SCID): report from Shanghai, China (2004-2011).
    Yao CM; Han XH; Zhang YD; Zhang H; Jin YY; Cao RM; Wang X; Liu QH; Zhao W; Chen TX
    J Clin Immunol; 2013 Apr; 33(3):526-39. PubMed ID: 23250629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency.
    Ozturk E; Catak MC; Kiykim A; Baser D; Bilgic Eltan S; Yalcin K; Kasap N; Nain E; Bulutoglu A; Akgun G; Can Y; Sefer AP; Babayeva R; Caki-Kilic S; Tezcan Karasu G; Yesilipek A; Ozen A; Karakoc-Aydiner E; Baris S
    J Clin Immunol; 2022 Jul; 42(5):1036-1050. PubMed ID: 35451701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API).
    Speckmann C; Nennstiel U; Hönig M; Albert MH; Ghosh S; Schuetz C; Brockow I; Hörster F; Niehues T; Ehl S; Wahn V; Borte S; Lehmberg K; Baumann U; Beier R; Krüger R; Bakhtiar S; Kuehl JS; Klemann C; Kontny U; Holzer U; Meinhardt A; Morbach H; Naumann-Bartsch N; Rothoeft T; Kreins AY; Davies EG; Schneider DT; Bernuth HV; Klingebiel T; Hoffmann GF; Schulz A; Hauck F
    J Clin Immunol; 2023 Jul; 43(5):965-978. PubMed ID: 36843153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review.
    Kalman L; Lindegren ML; Kobrynski L; Vogt R; Hannon H; Howard JT; Buckley R
    Genet Med; 2004; 6(1):16-26. PubMed ID: 14726805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
    Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
    Front Immunol; 2020; 11():1948. PubMed ID: 33178177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.
    Kwan A; Abraham RS; Currier R; Brower A; Andruszewski K; Abbott JK; Baker M; Ballow M; Bartoshesky LE; Bonilla FA; Brokopp C; Brooks E; Caggana M; Celestin J; Church JA; Comeau AM; Connelly JA; Cowan MJ; Cunningham-Rundles C; Dasu T; Dave N; De La Morena MT; Duffner U; Fong CT; Forbes L; Freedenberg D; Gelfand EW; Hale JE; Hanson IC; Hay BN; Hu D; Infante A; Johnson D; Kapoor N; Kay DM; Kohn DB; Lee R; Lehman H; Lin Z; Lorey F; Abdel-Mageed A; Manning A; McGhee S; Moore TB; Naides SJ; Notarangelo LD; Orange JS; Pai SY; Porteus M; Rodriguez R; Romberg N; Routes J; Ruehle M; Rubenstein A; Saavedra-Matiz CA; Scott G; Scott PM; Secord E; Seroogy C; Shearer WT; Siegel S; Silvers SK; Stiehm ER; Sugerman RW; Sullivan JL; Tanksley S; Tierce ML; Verbsky J; Vogel B; Walker R; Walkovich K; Walter JE; Wasserman RL; Watson MS; Weinberg GA; Weiner LB; Wood H; Yates AB; Puck JM; Bonagura VR
    JAMA; 2014 Aug; 312(7):729-38. PubMed ID: 25138334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.
    Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T
    J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Health Outcome and Quality of Life Post-HSCT for IL7Rα-, Artemis-, RAG1- and RAG2-Deficient Severe Combined Immunodeficiency: a Single Center Report.
    Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
    J Clin Immunol; 2018 Aug; 38(6):727-732. PubMed ID: 30105620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, Laboratory, and Molecular Findings for 63 Patients With Severe Combined Immunodeficiency: A Decade´s Experience.
    Fazlollahi MR; Pourpak Z; Hamidieh AA; Movahedi M; Houshmand M; Badalzadeh M; Nourizadeh M; Mahloujirad M; Arshi S; Nabavi M; Gharagozlou M; Khayatzadeh A; Dabbaghzade A; Atarod L; Zandieh F; Sadeghi Shabestary M; Mesdaghi M; Mohammadzadeh I; Mahdaviani SA; Eslamian MH; Pesaran F; Bahraminia E; Abolnezhadian F; Arij Z; Moin M
    J Investig Allergol Clin Immunol; 2017; 27(5):299-304. PubMed ID: 28266921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in RAG1 and RAG2 deficiency: 35 cases from a single-centre.
    Karaatmaca B; Cagdas D; Esenboga S; Erman B; Tan C; Turul Ozgur T; Boztug K; van der Burg M; Sanal O; Tezcan I
    Clin Exp Immunol; 2024 Feb; 215(2):160-176. PubMed ID: 37724703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives…one at a time.
    Quinn J; Orange JS; Modell V; Modell F
    Immunol Res; 2020 Feb; 68(1):48-53. PubMed ID: 32128663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.
    Dorsey MJ; Wright NAM; Chaimowitz NS; Dávila Saldaña BJ; Miller H; Keller MD; Thakar MS; Shah AJ; Abu-Arja R; Andolina J; Aquino V; Barnum JL; Bednarski JJ; Bhatia M; Bonilla FA; Butte MJ; Bunin NJ; Chandra S; Chaudhury S; Chen K; Chong H; Cuvelier GDE; Dalal J; DeFelice ML; DeSantes KB; Forbes LR; Gillio A; Goldman F; Joshi AY; Kapoor N; Knutsen AP; Kobrynski L; Lieberman JA; Leiding JW; Oshrine B; Patel KP; Prockop S; Quigg TC; Quinones R; Schultz KR; Seroogy C; Shyr D; Siegel S; Smith AR; Torgerson TR; Vander Lugt MT; Yu LC; Cowan MJ; Buckley RH; Dvorak CC; Griffith LM; Haddad E; Kohn DB; Logan B; Notarangelo LD; Pai SY; Puck J; Pulsipher MA; Heimall J
    J Clin Immunol; 2021 Jan; 41(1):38-50. PubMed ID: 33006109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data.
    Clément MC; Mahlaoui N; Mignot C; Le Bihan C; Rabetrano H; Hoang L; Neven B; Moshous D; Cavazzana M; Blanche S; Fischer A; Audrain M; Durand-Zaleski I
    J Allergy Clin Immunol; 2015 Jun; 135(6):1589-93. PubMed ID: 25840725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening.
    de Pagter AP; Bredius RG; Kuijpers TW; Tramper J; van der Burg M; van Montfrans J; Driessen GJ;
    Eur J Pediatr; 2015 Sep; 174(9):1183-8. PubMed ID: 25875249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features and HSCT Outcome for SCID in Turkey.
    Ikinciogullari A; Cagdas D; Dogu F; Tugrul T; Karasu G; Haskologlu S; Aksoylar S; Uygun V; Kupesiz A; Yildiran A; Gursel O; Ates C; Elhan A; Kansoy S; Yesilipek A; Tezcan I;
    J Clin Immunol; 2019 Apr; 39(3):316-323. PubMed ID: 30924026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.